Anti-DOT1L monoclonal antibody, clone FQS8428(3)

The aim of this study was to evaluate the immunomodulatory effects of two toxins from Bothrops snake venoms (the P-I metalloprotease Batroxase and the thrombin-like serine protease Moojase) on human peripheral blood mononuclear cells (PBMC), also investigating changes in the expression of genes related to epigenetic alterations and their immunotherapeutic potential. After 24 h of PBMC stimulation, Batroxase (2 mu g/mL) and Moojase (4 mu g/mL) increased some cytokine levels (including IL-6 and IL-10), but did not promote cell death processes (apoptosis/necrosis) or alterations in the global DNA methylation levels. Gene expression experiments (RTqPCR) showed that most of the genes with altered transcript levels encode enzymes that act on histones, such as acetyltransferases (HAT1), deacetylases (HDACs), methyltransferases (DOT1L) or demethylases (KDMSB), indicating that these toxins may alter gene regulation through epigenetic changes mainly related to histones and to methyl-CpG binding proteins (MECP2). Subsequently, the immunotherapeutic potential of these toxins was evaluated using in vitro cytotoxicity assays with NK cells and K562 leukemic cells. Both toxins were able to potentiate the NK cell cytotoxic effects against K562 tumor cells, and the effect of Batroxase was dependent on the concomitant stimulus with IL-2, whereas Moojase increased the NK cytotoxicity independently of IL-2. Thus, Batroxase and Moojase presented interesting immunomodulatory effects that could be explored for the development of new strategies in anticancer immunotherapies.

The global chromatin configuration is dramatically remodeled during fertilization and early preimplantation development. Although the chromocenters, which are pericentromeric heterochromatin clusters, are observed in the nuclei of oocytes, they disappear after fertilization and then reappear at the fourcell stage. To elucidate the mechanism of this reorganization of heterochromatin, we investigated the expression and nuclear localization of DOT1L, which is involved in the regulation of heterochromatin structure through histone H3 lysine 79 (H3K79) methyltransferase activity, during preimplantation development. The Dot1L mRNA level was low at the two-cell stage. In the analysis by the immunocytochemistry, DOT1L protein was not observed in the nuclei at this stage. Microinjection of Flag-tagged Dot1L cRNA revealed that the DOT1L protein was localized in the nucleus of the embryos at the onecell and four-cell stages but not at the two-cell stage. However, C-terminus-truncated DOT1L was localized in the nucleus of two-cell-stage embryos. Expression of the truncated DOT1L caused hypermethylation on H3K79 and the formation of chromocenter-like structures at the two-cell stage. Intriguingly, the expression of catalytically inactive truncated DOT1L also caused the formation of chromocenter-like structures without an increase in H3K79 methylation. Most embryos expressing the truncated DOT1L or its inactive form were arrested at the twocell stage. These results suggest that the absence of DOT1L, which is involved in the formation of a specific configuration of heterochromatin at the two-cell stage, is essential for early preimplantation development.